Focus: ImPact Biotech is a public Israeli biotech company focused on photodynamic therapies for oncology indications. The company operates at an early clinical stage with two Phase 1 programs in peripheral lung and pancreatic cancers.
Profile data last refreshed 8h ago · AI intelligence enriched 2w ago
Growing — net +14 jobs in 30d
47 jobs added vs 33 removed. Steady team buildout.
ImPact Biotech is a speculative early-stage bet suitable only for risk-tolerant candidates seeking deep technical expertise in photodynamic oncology with limited near-term de-risking catalysts.
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Help build intelligence for ImPact Biotech
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Generated by Claude from ImPact Biotech's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.
Based on last 4 crawl cycles
Upgrade to Pro to access AI interview prep brief and other premium pharma intelligence.
Upgrade to Pro — $25/mo